Derivation of human embryonic stem cells in defined conditions
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We have previously reported that high concentrations of basic fibroblast growth factor (bFGF) support feeder-independent growth of human embryonic stem (ES) cells, but those conditions included poorly defined serum and matrix components. Here we report feeder-independent human ES cell culture that includes protein components solely derived from recombinant sources or purified from human material. We describe the derivation of two new human ES cell lines in these defined culture conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the discovery of iPSC generation, the field has transitioned from using PSC culture media containing animal reagents to Xeno-free and even animal-free media [64,65,66].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [66]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationYing, Q.-L., Nichols, J., Chambers, I., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00847-x · Cited by 2,122
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109
Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C.-P., Harris, C. P., Waknitz, M. A., Itskovitz-Eldor, J., & Thomson, J. A. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9912 · Cited by 1,472
Self-citationBMP4 initiates human embryonic stem cell differentiation to trophoblast
Xu, R.-H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P., & Thomson, J. A. (2002) · Nature Biotechnology · doi:10.1038/nbt761 · Cited by 1,128
Self-citationRecurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
Self-citationBasic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells
Xu, R.-H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., & Thomson, J. A. (2005) · Nature Methods · doi:10.1038/nmeth744 · Cited by 973
Self-citationHuman embryonic stem cells express an immunogenic nonhuman sialic acid
Martin, M. J., Muotri, A., Gage, F., & Varki, A. (2005) · Nature Medicine · doi:10.1038/nm1181 · Cited by 932
Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1
Amit, M., Shariki, C., Margulets, V., & Itskovitz-Eldor, J. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.021147 · Cited by 664
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
Sperger, J. M., Chen, X., Draper, J. S., Antosiewicz, J. E., Chon, C. H., Jones, S. B., Brooks, J. D., Andrews, P. W., Brown, P. O., & Thomson, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235735100 · Cited by 648
Self-citation
Cited by
Items 601–700 of 1,000
Challenges for the Therapeutic use of Pluripotent Stem Derived Cells
Forsberg, M., & Hovatta, O. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00019 · Cited by 17
Xing, B., Yang, F., & Wu, X.-H. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.04.014 · Cited by 19
Nikmanesh, M., Cancel, L. M., Shi, Z., & Tarbell, J. M. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27104 · Cited by 17
Activin/Nodal Signaling and Pluripotency
Chng, Z., Vallier, L., & Pedersen, R. A. (2011) · Vitamins and hormones · doi:10.1016/b978-0-12-385961-7.00003-2 · Cited by 20
Matrix Revolutions: A Trinity of Defined Substrates for Long-Term Expansion of Human ESCs
Azarin, S. M., & Palecek, S. P. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.06.008 · Cited by 17
“Research into pathways that regulate self-renewal led to the development of multiple defined growth media, including mTeSR (Ludwig et al., 2006) and StemPro (Wang et al., 2007).”
BackgroundOliveri, R. S. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.5.795 · Cited by 17
Kishino, Y., Seki, T., Fujita, J., Yuasa, S., Tohyama, S., Kunitomi, A., Tabei, R., Nakajima, K., Okada, M., Hirano, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097397 · Cited by 18
“An animal product-free medium that supports the derivation and long-term feeder-independent culture of human ESCs was recently developed[16], and in the field of iPSC generation, many efforts have been made to remove potentially harmful agents from the culture system[17–20].”
BackgroundWilmes, A., Rauch, C., Carta, G., Kern, G., Meier, F., Posch, W., Wilflingseder, D., Armstrong, L., Lako, M., Beilmann, M., et al. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.07.023 · Cited by 19
Techniques in Embryoid Body Formation from Human Pluripotent Stem Cells
Shevde, N. K., & Mael, A. A. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-128-8_33 · Cited by 17
Akutsu, H., Cowan, C. A., & Melton, D. A. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)18005-2 · Cited by 17
Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells
Floy, M. E., Shabnam, F., Simmons, A. D., Bhute, V. J., Jin, G., Friedrich, W. A., Steinberg, A. B., & Palecek, S. P. (2022) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-092120-033922 · Cited by 18
Wang, P., Zhu, P., Yu, C., & Wu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873662 · Cited by 18
“Some growth factors or physical factors, such as basic fibroblast growth factor (bFGF) (12), transforming growth factor-b (TGF-b) (13), and oxygen level (14), play a decisive role in stromal cell survival or proliferation.”
Zhang, L., Zheng, W., Wang, Y., Wang, Y., & Huang, H. (2013) · Cellular Reprogramming · doi:10.1089/cell.2012.0064 · Cited by 16
“Although feeder-free cultures of hESCs and hiPSCs have been developed (Li et al., 2005; Ludwig et al., 2006; Nagaoka et al., 2010), they may be a hostile environment and are more prone to lead to karyotypic abnormalities in hESCs and hiPSCs (Catalina et al., 2008; Imreh et al., 2006).”
BackgroundHöfner, T., Macher‐Goeppinger, S., Klein, C., Rigo‐Watermeier, T., Eisen, C., Pahernik, S. A., Hohenfellner, M., Trumpp, A., & Sprick, M. R. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.06.053 · Cited by 16
“To establish a cell culture model for NEBC we tested a combination of growth factors and tissue culture surfaces that allow the propagation of normal and cancer stem cells in vitro.(8,9) Serum-free medium and Ultra-Low Adhesion Flasks were used because NEBC cells did not grow with standard”
MethodUsing human pluripotent stem cells to untangle neurodegenerative disease mechanisms
Malgrange, B., Borgs, L., Grobarczyk, B., Purnelle, A., Ernst, P., Moonen, G., & Nguyen, L. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0557-6 · Cited by 17
“More recently, a fully defined medium named TeSR1 has been designed and was able to maintain the pluripotency of different human cell lines [42].”
Derivation of Man-1 and Man-2 research grade human embryonic stem cell lines
Camarasa, M. V., Kerr, R. W., Sneddon, S., Bates, N., Shaw, L., Oldershaw, R. A., Small, F., Baxter, M. A., McKay, T. R., Brison, D. R., et al. (2010) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-010-9291-5 · Cited by 16
Crook, J. M., Wallace, G. G., & Tomaskovic‐Crook, E. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1013096 · Cited by 18
“, to simplify process and facilitate scale-up from laboratory-based research to industrial-scale biomedicine) and incorporate specialist media, for example, mTeSR [110,111], StemPro (Life Technologies) and Essential 8 (Life Technologies) [114], with more or less complex substrates such as Matrigel (Becton-Dickenson; a…”
Anisimov, S. V., Christophersen, N. S., Correia, A. S., Hall, V. J., Sandelin, I., Li, J., & Brundin, P. (2010) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-010-0039-8 · Cited by 16
“It is generally recognized that feeder cells (including MEF and hFF) are only able to support the proliferation of hESC in an undifferentiated condition for a limited number of passages, from 11-12 to 15 for hFF [3, 4] and from 3-4 to 6-7 for MEF [9].”
Geng, Y., Zhao, Y., Schuster, L. C., Feng, B., Lynn, D. A., Austin, K. M., Stoklosa, J. D., & Morrison, J. D. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.09.023 · Cited by 16
Mechanisms of action of hESC-secreted proteins that enhance human and mouse myogenesis
Yousef, H., Conboy, M. J., Mamiya, H., Zeiderman, M., Schlesinger, C., Schaffer, D. V., & Conboy, I. M. (2014) · Aging · doi:10.18632/aging.100659 · Cited by 18
“FGF2 is a wellknown mitogen and critical component of adult and embryonic stem cell culture medium [23], and enhances the proliferation of already activated myoblasts [17, 24, 25].”
BackgroundDevelopment of a European Human Embryonic Stem Cell Registry
Borstlap, J., Kurtz, A., Stacey, G., Elstner, A., Damaschun, A., Arán, B., Gerlach, J., Belmonte, J. C. I., & Veiga, A. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.6.945 · Cited by 16
Propagating pluripotency – The conundrum of self‐renewal
Smith, A. G. (2024) · BioEssays · doi:10.1002/bies.202400108 · Cited by 15
Haus, D. L., Nguyen, H. X., Gold, E. M., Kamei, N., Perez, H. D., Moore, H. D. M., Anderson, A. J., & Cummings, B. J. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.06.008 · Cited by 16
“…or in vivo studies, XF adherent hNSCs had, at a minimum, been cultured in XF conditions for over 100 days (40 – 60 days as XF hESC, followed by 60+ days as XF hNSC spheres/monolayer), a time period sufficient to eliminate detectable non-human molecules (Ludwig et al., 2006; Heiskanen et al., 2007).”
Wang, L., Huang, D., Huang, C., Yin, Y., Vali, K., Zhang, M., & Tang, Y. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.10.014 · Cited by 15
Jiang, Z., Li, Y., Ji, X., Tang, Y., Yu, H., Ding, L., Yu, M., Cui, Q., Zhang, M., Ma, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15081-6 · Cited by 15
Park, T. S., Zimmerlin, L., Evans-Moses, R., & Zambidis, E. T. (2018) · Journal of Visualized Experiments · doi:10.3791/57921 · Cited by 17
Ideno, H., Imaizumi, K., Shimada, H., Sanosaka, T., Nemoto, A., Kohyama, J., & Okano, H. (2022) · iScience · doi:10.1016/j.isci.2022.105140 · Cited by 15
“The contamination of mouse-derived cells is also unfavorable for the clinical application of PSCs. Recent advances have made it possible to maintain PSCs without feeder cells under defined culture conditions (Chen et al., 2011; Ludwig et al., 2006; Nakagawa et al., 2015).”
BackgroundTomaskovic‐Crook, E., Higginbottom, S. L., Zhang, B., Bourke, J., Wallace, G. G., & Crook, J. M. (2023) · Organoids · doi:10.3390/organoids2010002 · Cited by 16
“However, although enabling robust cell culture with chemically defined medium such as mTeSRTM1 [8], and while MatrigelTM remains one of the most widely used substrates for human PSC support and differentiation, feeder-based systems are unnecessarily complex and MatrigelTM comprises undefined components, being derived…”
BackgroundMicroarrayed materials for stem cells
Mei, Y. (2012) · Materials Today · doi:10.1016/s1369-7021(12)70196-7 · Cited by 18
Human cord blood applications in cell therapy: looking back and look ahead
Zhou, H., Chang, S., & Rao, M. S. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.691161 · Cited by 15
“Serum-free culture conditions using chemically definedmedium containing activin A, nodal and bFGF [38], and using xeno-free defined medium with bFGF, LiCl, GABA, TGFb and pipeolic acid has also been developed [39].”
MethodGP130 signaling and the control of naïve pluripotency in humans, monkeys, and pigs
Bourillot, P.-Y., Santamaria, C., David, L., & Savatier, P. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111712 · Cited by 15
Mimicking Physiological Oxygen in Cell Cultures
Forsyth, N. R., Steeg, R., Ahmad, M., Al-Zubaidi, M. A., Al-Jumaily, R. M. K., Merkhan, M. M., & Dale, T. P. (2018) · Learning materials in biosciences · doi:10.1007/978-3-319-74854-2_8 · Cited by 14
The building blocks of embryo models: embryonic and extraembryonic stem cells
Ren, H., Jia, X., & Yu, L. (2025) · Cell Discovery · doi:10.1038/s41421-025-00780-6 · Cited by 14
“However, human ESCs have been derived from the inner cell mass (ICM) of human pre-implantation embryos 8,98,99 Red ( − ), pathway inhibition.”
Potential for pharmacological manipulation of human embryonic stem cells
Atkinson, S. P., Lako, M., & Armstrong, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01978.x · Cited by 14
Jaremko, K. L., & Marikawa, Y. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.04.002 · Cited by 14
“A small amount (e.g.,10 ng/mL) of Activin A or TGFβ1 is an essential ingredient in the chemically defined culture media that are formulated for routinemaintenance of hESCs under feeder-free conditions (Amit et al., 2004; Brons et al., 2007; Ludwig et al., 2006).”
BackgroundHuman cystic fibrosis embryonic stem cell lines derived on placental mesenchymal stromal cells
Deleu, S., Gonzalez-Merino, E., Gaspard, N., Nguyen, T., Vanderhaeghen, P., Lagneaux, L., Toungouz, M., Englert, Y., & Devreker, F. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60018-1 · Cited by 14
“For example, one of the two hESC derived on a human matrix became triploid for chromosome 12 (Ludwig et al., 2006).”
BackgroundHarvey, A. J., O’Brien, C., Lambshead, J., Sheedy, J. R., Rathjen, J., Laslett, A. L., & Gardner, D. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193949 · Cited by 14
“Cell lines were transferred from their original culture conditions to mTeSR1TM medium (Stem Cell Technologies, Vancouver, Canada) [41] on ES-cell qualified MatrigelTM (Corning Life Sciences, Tewksbury, MA, USA)–coated tissue culture plates (Corning Life Sciences) and maintained at 37 ̊C in an atmosphere of 5% CO2 in a…”
MethodLynch, E. M., Robertson, S., FitzGibbons, C., Reilly, M. L., Switalski, C., Eckardt, A., Tey, S.-R., Hayakawa, K., & Suzuki, M. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113815 · Cited by 14
Joddar, B., Nishioka, C., Takahashi, E., & Ito, Y. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01635a · Cited by 15
Quang, T., Marquez, M., Blanco, G., & Zhao, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086031 · Cited by 14
“that also supports hESCs culture on matrigel [26].”
BackgroundZhou, H., Yong, J., Sun, X., Wang, C., Yang, W., Zhang, P., Zhu, J., Shi, C., Ding, M., & Deng, H. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00280.x · Cited by 14
Growth of Human Embryonic Stem Cells Using Derivates of Human Fibroblasts
Escobedo‐Lucea, C., & Stojković, M. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-369-5_3 · Cited by 14
Engineered Micromechanical Cues Affecting Human Pluripotent Stem Cell Regulations and Fate
Nampe, D. P., & Tsutsui, H. (2013) · SLAS TECHNOLOGY · doi:10.1177/2211068213503156 · Cited by 16
López-Fagundo, C., Livi, L. L., Ramchal, T. D., Darling, E. M., & Hoffman–Kim, D. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.04.047 · Cited by 14
“Some advances in defining culture conditions have not been sufficient to prevent the spontaneous differentiation of hESCs [35] or, alternatively, require the use of recombinant proteins [36].”
BackgroundMutated Human Embryonic Stem Cells for the Study of Human Genetic Disorders
Ben‐Yehudah, A., Malcov, M., Frumkin, T., & Ben‐Yosef, D. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-794-1_11 · Cited by 15
Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery
Christensen, K., Roudnicky, F., Patsch, C., & Burcin, M. M. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_23 · Cited by 14
Optimal human iPS cell culture method for efficient hepatic differentiation
Matoba, N., Yamashita, T., Takayama, K., Sakurai, F., & Mizuguchi, H. (2018) · Differentiation · doi:10.1016/j.diff.2018.09.005 · Cited by 14
Ellerström, C., Hyllner, J., & Strehl, R. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-369-5_7 · Cited by 14
Ahmadian Baghbaderani, B., Tian, X., Scotty Cadet, J., Shah, K., Walde, A., Tran, H., Kovarcik, D. P., Clarke, D., & Fellner, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161229 · Cited by 13
The occurrence and development of induced pluripotent stem cells
Chen, Y., Li, M., & Wu, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1389558 · Cited by 18
Kishino, Y., Seki, T., Yuasa, S., Fujita, J., & Fukuda, K. (2015) · Journal of Visualized Experiments · doi:10.3791/53225 · Cited by 14
Lee, J. B., Graham, M., Collins, T. J., Lee, J., Hong, S., Mcnicol, A. J., Shapovalova, Z., & Bhatia, M. (2015) · Stem Cells · doi:10.1002/stem.1952 · Cited by 14
Chemische Kontrolle des Schicksals und Entwicklungspotenzials von Stammzellen
Lyssiotis, C. A., Lairson, L. L., Boitano, A. E., Wurdak, H., Zhu, S., & Schultz, P. G. (2010) · Angewandte Chemie · doi:10.1002/ange.201004284 · Cited by 13
Zhang, L., Xu, Y., Xu, J., Wei, Y., & Xu, X. (2016) · Human Reproduction · doi:10.1093/humrep/dew011 · Cited by 13
Engineering Concepts in Stem Cell Research
Narayanan, K., Mishra, S., Singh, S., Pei, M., Gulyás, B. Z., & Padmanabhan, P. (2017) · Biotechnology Journal · doi:10.1002/biot.201700066 · Cited by 14
Calcineurin A gamma and NFATc3/SRPX2 axis contribute to human embryonic stem cell differentiation
Chen, H., Zeng, Y., Shao, M., Zhao, H., Fang, Z., Gu, J., Liao, B., & Jin, Y. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30255 · Cited by 13
Embryonic stem cells as a cell source for tissue engineering
Khademhosseini, A., Ashammakhi, N. A., Karp, J. M., Gerecht, S., Ferreira, L., Annabi, N., Darabi, M. A., Sirabella, D., Vunjak‐Novakovic, G., & Langer, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00027-7 · Cited by 16
Tang, C. Z., Weissman, I. L., & Drukker, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-478-4_2 · Cited by 17
“To circumvent the possibility of xenoantigen incorporation, several laboratories have developed methods to derive and culture hPSCs without animal products [21,22,23,24].”
BackgroundKing, C. C., Beattie, G. M., Lopez, A. D., & Hayek, A. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.2.175 · Cited by 15
Badenes, S. M., Fernandes, T. G., Cordeiro, C. S. M., Boucher, S., Kuninger, D., Vemuri, M. C., Diogo, M. M., & Cabral, J. M. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155296 · Cited by 14
Loh, K. M., Zheng, S. L., Liu, K. J., Yin, Q., Amir-Ugokwe, Z. A., Jha, S. K., Qi, Y., Wazny, V. K., Nguyen, A. T., Chen, A. C., et al. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103494 · Cited by 12
Trans-spliced long non-coding RNA: an emerging regulator of pluripotency
Yu, C., Chuang, C.-Y., & Kuo, H. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2862-4 · Cited by 13
Fonoudi, H., Lyra‐Leite, D. M., Javed, H., & Burridge, P. W. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.110 · Cited by 12
Derivation and Propagation of hESC Under a Therapeutic Environment
Sidhu, K., Walke, S., & Tuch, B. E. (2008) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc01a04s6 · Cited by 12
Frampton, J. P., Shi, H., Kao, A., Parent, J. M., & Takayama, S. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300049 · Cited by 12
Doran, M. R., Markway, B. D., Croll, T. I., Sara, S., Munro, T. P., & Cooper-White, J. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.033 · Cited by 12
“Unlike nickel, zinc is a standard supplement in serum-free medium [18,19].”
BackgroundOptimized Protocol for Derivation of Human Embryonic Stem Cell Lines
Camarasa, M. V., Gálvez, V. M., Brison, D. R., & Bachiller, D. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9377-4 · Cited by 13
Swelstad, B. B., & Kerr, C. L. (2009) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s8051 · Cited by 15
Rajala, K., Vaajasaari, H., Suuronen, R., Hovatta, O., & Skottman, H. (2011) · Stem Cell Studies · doi:10.4081/scs.2011.e3 · Cited by 16
Separation and maintenance of normal cells from human embryonic stem cells with trisomy 12 mosaicism
Seol, H. W., Oh, S. K., Park, Y. B., Kim, H. S., Baek, J. A., Seo, J. Y., Kim, E. H., Ku, S., Kim, S. H., Choi, Y. M., et al. (2008) · Chromosome Research · doi:10.1007/s10577-008-1258-y · Cited by 12
“Abnormalities such as trisomy 12 and aberrant chromosome X number were also reported in feeder-free cultures of hESCs using defined media (Ludwig et al. 2006).”
BackgroundCapturing the ephemeral human pluripotent state
Ávila‐González, D., García-López, G., García‐Castro, I. L., Flores‐Herrera, H., Molina‐Hernández, A., Portillo, W., & Díaz, N. F. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24405 · Cited by 12
“For example, abnormal hESC karyotypes have been reported during long-term culture on Matrigel with defined medium (Ludwig et al., 2006).”
BackgroundMaintenance of hPSCs under Xeno-Free and Chemically Defined Culture Conditions
Lim, J. J., Kim, H. J., Rhie, B., Lee, M. R., Choi, M. J., Hong, S.-H., & Kim, K.-S. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc19090 · Cited by 12
“This first defined medium significantly improved hESC culture, and was commercially released as TeSR1, becoming the most widely-published feeder-free medium, used in over 1,100 peerreviewed publications.”
BackgroundInfluentialRegenerative Medicine for Diabetes
Bose, B., Katikireddy, K. R., & Sudheer Shenoy, P. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800174-5.00009-0 · Cited by 15
Characterization and Evaluation of Human Embryonic Stem Cells
Xu, C. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)20002-8 · Cited by 13
Xing, B., Wang, L., Li, Q., Cao, Y., Dong, X., Liang, J., & Wu, X. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.05.009 · Cited by 12
“[16] Ludwig TE, LevensteinME, Jones JM, BerggrenWT, Mitchen ER, Frane JL, et al.”
MethodShi, Q. S., Hodara, V. L., Simerly, C. R., Schatten, G. P., & VandeBerg, J. L. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0313 · Cited by 12
Cervera, R. P., & Stojković, M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100278 · Cited by 13
The Origins of Human Embryonic Stem Cells: A Biological Conundrum
Brink, T. C., Sudheer, S., Janke, D., Jagodzinska, J., Jung, M., & Adjaye, J. (2007) · Cells Tissues Organs · doi:10.1159/000112843 · Cited by 12
Induced Pluripotent Stem Cells from Nonhuman Primates
Mishra, A., Qiu, Z., Farnsworth, S. L., Hemmi, J. J., Li, M., Pickering, A. V., & Hornsby, P. J. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_159 · Cited by 12
“Some advances described for human cells, such as the use of TeSR1 medium – the first defined medium described for human pluripotent cells (6) – have not been found”
Borys, B. S., Dang, T., Worden, H., Larijani, L., Corpuz, J. M., Abraham, B. D., Gysel, E. J., Malinovska, J., Krawetz, R., Révay, T., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03819-9 · Cited by 11
Liberski, A. R., Al-Noubi, M. N., Rahman, Z. H., Halabi, N. M., Dib, S. S., Mismar, R. A., Billing, A. M., Krishnankutty, R., Ahmad, F. S., Raynaud, C. M., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400099j · Cited by 11
Zhou, P., Qin, L., Ge, Z., Xie, B., Huang, H., He, F., Ma, S., Ren, L., Shi, J., Pei, S., et al. (2022) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35034 · Cited by 12
Culture environment regulates amino acid turnover and glucose utilisation in human ES cells
Rathjen, J., Yeo, C. X., Yap, C., Tan, B. S. N., Rathjen, P. D., & Gardner, D. K. (2013) · Reproduction Fertility and Development · doi:10.1071/rd12276 · Cited by 11
Engineering Human Embryonic Stem Cell Differentiation
Korin, N., & Levenberg, S. (2007) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2007.10648102 · Cited by 14
Study of transforming growth factor alpha for the maintenance of human embryonic stem cells
Chen, A. C. H., Lee, Y. L., Hou, D. Y. C., Fong, S. W., Peng, Q., Pang, R. T. K., Chiu, P. C. N., Ho, P., Lee, C., & Yeung, W. S. B. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1476-7 · Cited by 11
“Current researches into hESC culture have concentrated on the development of defined culture conditions without the use of feeder cells (Li et al. 2005; Ludwig et al. 2006).”
BackgroundLi, Y., Yokohama‐Tamaki, T., & Tanaka, T. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021355 · Cited by 11
“To eliminate the effects of unknown components in animal sera as well as the contamination of animal products, chemicallydefined serum-free culture methods have been established [14,26,27,28].”
MethodHao, J., Sawyer, D. B., Hatzopoulos, A. K., & Hong, C. C. (2011) · Recent Patents on Regenerative Medicine · doi:10.2174/2210296511101030263 · Cited by 11
“For instance, the KnockOut Serum Replacement can replace serum for culturing ES and iPS cells [18], and the mTeSR was specifically formulated to maintain hES cells and iPS cells in serum-free and feeder-free conditions [19].”
MethodLi, Y., Drnevich, J. M., Akraiko, T., Band, M., Li, D., Wang, F., Matoba, R., & Tanaka, T. S. (2013) · Genomics · doi:10.1016/j.ygeno.2013.09.004 · Cited by 12
“The self-renewal of human ESCs is dependent on the TGFβ and bFGF signals [77,78], which are known to interact with the Shh signal [79,80].”
BackgroundMartin, U. (2009) · Springer eBooks · doi:10.1007/978-3-540-88806-2 · Cited by 13
An Overview of Pluripotent Stem Cells
Bhartiya, D., Nagvenkar, P. V., Sriraman, K., & Shaikh, A. (2013) · InTech eBooks · doi:10.5772/55130 · Cited by 13
“Attempts have been made to derive new hES cell lines in more defined conditions including serum-free or feeder-free conditions in the presence of extracellular matrices such as matrigel and fibronectin [43-45].”
BackgroundReview of the role of basic fibroblast growth factor in dental tissue-derived mesenchymal stem cells
Nowwarote, N., Sawangmake, C., Pavasant, P., & Osathanon, T. (2017) · Asian Biomedicine · doi:10.5372/1905-7415.0903.395 · Cited by 14
A Single-Cell and Feeder-Free Culture System for Monkey Embryonic Stem Cells
Ono, T., Suzuki, Y., Kato, Y., Fujita, R., Araki, T., Yamashita, T., Kato, H., Torii, R., & Sato, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088346 · Cited by 13
“Most culture systems are based on an MEF-conditioned medium (MEF-CM) or commercial media such as mTeSR1 [11,12] and StemPro [13] and/or animal-derived products such as Matrigel, a complex mixture of matrix proteins [14].”
BackgroundShahbazi, M., Cundiff, P., Zhou, W., Lee, P., Patel, A., D’Souza, S. L., Abbasi, F., Quertermous, T., & Knowles, J. W. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1319-5 · Cited by 12
A lncRNA-miRNA-mRNA network for human primed, naive and extended pluripotent stem cells
Ma, Z., Li, Y., Zhang, Y., Chen, J., Tan, T., & Fan, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234628 · Cited by 11
“MTeSRTM1 medium (STEMCELL Technologies), containing recombinant human basic fibroblast growth factor (rhbFGF) and recombinant human transforming growth factor β (rh TGFβ), is a complete, serum-free, defined formulation designed for the feeder-free maintenance and expansion of hESCs and hiPSCs [25,26].”
BackgroundStrategies for future histocompatible stem cell therapy
Nehlin, J. O., & Barington, T. (2009) · Biogerontology · doi:10.1007/s10522-009-9213-7 · Cited by 11
“…hESC are seeded onto non-dividing embryonic fibroblasts of either mouse or human origin (Thomson et al. 1998; Meng et al. 2008), and a feeder-free culture consisting of hESC growing on a membrane matrix commonly known as Matrigel basement membrane matrix (Xu et al. 2001; Ludwig et al. 2006a, b).”
BackgroundBlow, N. S. (2008) · Nature · doi:10.1038/451855a · Cited by 11
Lermant, A., Rabussier, G., Davidson, L., Lanz, H. L., & Murdoch, C. E. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.102879 · Cited by 10
Stemazole promotes survival and preserves stemness in human embryonic stem cells
Sun, Y., Zhang, X., Li, H., Xu, S., Zhang, X., Liu, Y., Han, M., & Wen, J. (2017) · FEBS Journal · doi:10.1111/febs.14355 · Cited by 10
A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells
Jurlina, S. L., Jones, M. K., Agarwal, D., Toba, D. V. D. L., Kambli, N. K., Su, F., Martin, H. M., Anderson, R. J., Wong, R. M., Seid, J., et al. (2022) · Genes · doi:10.3390/genes13122363 · Cited by 10
Moon, S., Kim, J. M., Hong, K., Shin, J. M., Kim, J., & Chung, H.-M. (2011) · International Journal of Stem Cells · doi:10.15283/ijsc.2011.4.1.24 · Cited by 11
“More recently, a completely defined, animal-free medium, TeSR1, which does not contain bovine serum albumin (BSA), has been introduced (61).”
Background
Metadata
- Authors
- Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., Llanas, R. A., & Thomson, J. A.
- Affiliations
- WiCell (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Thomson, James A
- Venue
- Nature Biotechnology
- Published
- 2006-01-01
- Volume
- 24
- Issue
- 2
- Pages
- 185-187
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2038723730
- Cited by
- 1,114
- References
- 15
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 20 · 2023: 25 · 2022: 26 · 2021: 28 · 2020: 31 · 2019: 31 · 2018: 34 · 2017: 48 · 2016: 39 · 2015: 55 · 2014: 65 · 2013: 80 · 2012: 85
- FWCI
- 43.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r24rr017721-04)
- U.S. Public Health Service (P20-GMO69981)
- National Center for Research Resources (R24-RR017721)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- human embryonic stem cells, defined culture conditions, basic fibroblast growth factor, recombinant growth factors, stem cell derivation, stem cell lines, serum-free culture
- MeSH terms
- Cell Differentiation, Cell Line, Cell Survival, Culture Media, Humans, Stem Cells, Cell Culture Techniques, Tissue Engineering, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.